Cytovale Revenue and Competitors

Location

#1705

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Cytovale's estimated annual revenue is currently $17.5M per year.(i)
  • Cytovale's estimated revenue per employee is $155,000
  • Cytovale's total funding is $107M.

Employee Data

  • Cytovale has 113 Employees.(i)
  • Cytovale grew their employee count by 47% last year.

Cytovale's People

NameTitleEmail/Phone
1
Co-Founder & CEOReveal Email/Phone
2
Co-Founder & CTOReveal Email/Phone
3
EVP SalesReveal Email/Phone
4
EVP, CommercialReveal Email/Phone
5
EVP, PeopleReveal Email/Phone
6
EVP, SalesReveal Email/Phone
7
VP - Quality & Regulatory ComplianceReveal Email/Phone
8
Chief Medical OfficerReveal Email/Phone
9
Senior Director MFG Engineering & OperationsReveal Email/Phone
10
Director, Quality Assurance and Regulatory AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Cytovale?

Cytovale, based in San Francisco, Calif., is a medical technology company dedicated to revolutionizing diagnostics using cell mechanics and machine learning, and applying this first to sepsis, a condition whose early detection dramatically improves patient outcomes.

keywords:N/A

$107M

Total Funding

113

Number of Employees

$17.5M

Revenue (est)

47%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cytovale News

2022-03-22 - Cytovale™ IntelliSep™ Test Demonstrates Potential to Rapidly Risk ...

Cytovale is a medical diagnostics company focused on providing rapid and insightful tools to improve early detection of fast-moving and immune-...

2019-10-30 - Cytovale Raises $15M in Funding

Cytovale, Inc., a San Francisco, Calif.-based medical technology company dedicated to innovating diagnostics using cell mechanics and machine learning, raised $15m in financing. The company raised $7.4m in an extension of Series B equity financing, co-led by existing investors Breakout Ventures ...

2013-11-15 - CytoVale Receives Investment from Breakout Labs

CytoVale, a San Francisco, CA-based developer of a new class of biomarkers based on the mechanical properties of individual cells, or mechanomics, received an investment of undisclosed amount. Breakout Labs, the program of the Thiel Foundation, which invests in early-stage science and technolog ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.7M11333%N/A
#2
$17M11330%N/A
#3
$28.4M1138%$25M
#4
$15.8M1137%N/A
#5
$15M113-3%N/A